VERTEX PHARMACEUTICALS INC / MA ($VRTX)
Bunnage Mark E. โ EVP, Chief Scientific Officer
Shares
1,182
Price
$473.68
Total Value
$559,889.76
Nearby Earnings
Feb 9, 2026
EPS:Est: 5.05
Revenue:Est: $3.18B
Feb 12, 2026
EPS:5.03 (est: 5.11)-1.6%
Revenue:$3.23B (est: $3.18B)+1.4%
Transaction Details
| Insider | Bunnage Mark E. |
|---|---|
| Title | EVP, Chief Scientific Officer |
| Transaction Date | Feb 18, 2026 |
| Transaction Code | S Sale |
| Acquired/Disposed | Disposed |
| Security | Common Stock |
| Direct/Indirect | Direct |
| Filing Date | Feb 19, 2026 |
| Document Date | Feb 17, 2026 |
| Shares Sold | 1,182 |
| Price per Share | $473.68 |
| Total Value | $559,889.76 |
| Shares Owned After | 8,486 |
| Derivative | No |
| Accession Number | 0000875320-26-000088 |
| Document | View SEC Filing |